🔎 Trials Near Me

Hjem › Akut lymfoblastisk leukæmi › Oklahoma

Akut lymfoblastisk leukæmi kliniske forsøg i Oklahoma

8 studier for Akut lymfoblastisk leukæmi søger deltagere på steder i Oklahoma.

Byer i Oklahoma

Officiel studietekst (engelsk)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Hospital Oklahoma City, Oklahoma City
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

  • Board of Regents of the University of Oklahoma Health Sciences Center, Oklahoma City
RekruttererObservationsstudie
1 Day – 17 Years · Alle køn · Opdateret 14. aug. 2026 · NCT06274788

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

  • Saint Francis Children's Hospital, Tulsa
RekruttererFase 2
Alder 1 til 18 · Alle køn · Opdateret 16. jul. 2026 · NCT06533748

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

  • Saint Francis Children's Hospital, Tulsa
RekruttererFase 4
Alder 1 til 18 · Alle køn · Opdateret 14. jul. 2026 · NCT06289673

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of Oklahoma Health Science Center, Oklahoma City
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT01351545

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • University of Oklahoma Health Sciences Center, Oklahoma City
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 18. maj 2026 · NCT01790152

Pilot Imaging Study of Leukemia

  • University of Oklahoma Health Sciences Center, Oklahoma City
RekruttererFase 1
Alder 4 til 80 · Alle køn · Opdateret 23. apr. 2026 · NCT03633955

Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.